ABSTRACT (P = 0.10; 3.0 vs. 1.7% for 0.4M and 0.5M, respectively
INTRODUCTION
Melengestrol acetate (MGA; Pfizer Animal Health, New York, NY) is an orally active progestogen that has been commercially available since 1968 as a feed additive to improve feed utilization and growth rate, and to suppress expression of estrus in feedlot heifers (Bloss et al., 1966; O'Brien et al., 1968; Lauderdale, 1983 ). However, current production scenarios including different nutrition strategies, implant strategies, feed additives, marketing specifications, and cattle genotypes result in a different level of production expectation than for cattle produced a few decades ago.
To achieve optimal feed conversion and growth and the highest degree of estrus suppression from MGA, a dose level of 0.35 to 0.50 mg/d per heifer has been recommended (Bloss et al., 1966; Zimbelman and Smith, 1966) . Differences in performance associated with varying dosages of MGA within its recommended levels have not received much attention under current management practices. Therefore, the objective of this study was to compare the effects of MGA supplied at 0.4 versus 0.5 mg/d per heifer in the finishing ration on estrus activity, ADG, G:F, and carcass characteristics of finishing feedlot heifers.
MATERIALS AND METHODS

Animal Management
This study was conducted in a manner consistent with applicable laws and regulations governing the humane care of animals. Heifers were observed at least once daily to ensure animals were healthy, and, if any abnormality was detected, to ensure prompt and adequate treatment by a qualified veterinarian.
Commercial feedlot heifers of mixed breeds (n = 1,418; 9 to 14 mo of age; initial BW = 290 ± 1.9 kg) were used in a randomized complete block design study conducted at a commercial research facility near Syra-cuse, Kansas (Bos Technica Research Services Inc.). Experimental blocks were composed of 2 pens based on location, with a total of 20 pens (10 blocks). Heifers were housed in dirt pens that were 21.3 × 91.4 m in size, with individual pen flow water tanks (1 × 3.7 m) and 19.5 linear meters of fence-line bunk space per pen. Cattle were processed by arrival date (March 5 through March 28, 2007) and randomly assigned 10 head at a time to pens within an experimental block until the desired head count in each pen was attained (70 to 75 heifers/ pen). Each block consisted of 2 pens randomly assigned to 1 of 2 MGA dose levels: 0.4 (0.4M) or 0.5 (0.5M) mg/d per head.
Based on evaluation of heifers upon arrival, cattle were excluded from the study if they required therapy for any injury or nonrespiratory disease, exhibited clinical signs of bovine respiratory disease, exhibited conditions that could have affected their response to bovine respiratory disease treatments, were noticeably pregnant, or were bulls or steers. At the beginning of the study, there were 709 cattle in each treatment. Five steers were identified (n = 3 in the 0.4M group, and n = 2 in the 0.5M group) and removed from the study after initial enrollment. One heifer was killed because of injury, and 6 heifers died as a result of digestive problems (bloat). A total of 5 additional heifers were rejected from the study shortly after enrollment for chronic respiratory problems, founder, abscesses, or mechanical problems. Heifers completing the study were slaughtered at a commercial beef-packing facility (National Beef, Liberal, KS) .
Within 48 h after allotment to the research pens, heifers were processed and received a unique identification number and tag with both a visual drop-down tag and an electronic tag in the left ear. 
Diet and Feeding
Diets were formulated to meet or exceed NRC (1996) requirements and fed for ad libitum consumption. Heifers were adjusted to a 95% concentrate final diet using a series of 3 step-up diets, with MGA included only in the final diet (Table 1) . Heifers were adjusted to the finishing diet within 5 wk after arrival. Cattle were fed 3 times daily and the amount of feed delivered to each pen was recorded for each feeding. Feed weigh-backs were recorded for each pen as needed throughout the study. Weighed-back feed was determined on a DM basis using a laboratory convection oven on site. Total feed intake per pen was calculated on a DM basis as the amount of feed offered minus the weighed-back portion of feed. Daily feed intake was then calculated as total feed intake divided by total animal days, where total animal days was equal to the number of days each heifer was in its home pen from start to finish of the study, totaled for each pen.
Daily Observations
Daily observations of abnormal conditions (morbidity, mortality, and adverse reactions) were performed by trained personnel. Animals that required treatment were taken from their pens, treated, and returned to their home pens according to standard feedlot therapy. Animals that either died or were killed underwent necropsy by a qualified veterinarian to assess the cause of death. For heifers removed from the study, a qualified veterinarian diagnosed the cause of removal. Estrus detection observations were conducted twice daily (morning and afternoon) for approximately 10 min by trained personnel. Frequency of estrus activity was recorded while heifers were fed the finishing diet. Estrus was determined by heifers exhibiting standing heat. Observed estrus activity was recorded on a daily basis as the total number of heifers exhibiting standing estrus within a pen during each observation.
Live Performance
Pen BW was recorded at processing and just before slaughter. Initial BW was calculated as the pen BW at processing divided by the number of heifers placed. Final shrunk BW was calculated as the pen BW before slaughter × 0.96 divided by the number of heifers shipped for slaughter. An adjustment of 4% was applied to final pen BW to account for shrink associated with rumen fill. Total pen BW gain was calculated as the differences between final and initial BW and daily BW gain was calculated as total BW gain divided by the average number of days on feed.
Carcass Characteristics
Heifers were slaughtered by block on 1 of 2 d (September 4 or 17, 2007) . All heifers within a block were slaughtered on the same day. Average days on feed was 176 and ranged from 166 to 182. Carcass data were collected at the time of slaughter by USDA meat graders and an independent carcass collection team (Cattle Trail Inc., Johnson, KS). Carcass measures included hot carcass weight, dressing percentage, 12th-rib fat thickness, LM area, marbling score, USDA QG and YG, liver abscess incidence, KPH, empty body fat percentage, cutability percentage, and presence of darkcutting carcasses within a pen. Liver abscesses were scored according to the 3-point scale described by Elanco (1974) .
Statistical Analysis
The response variables of interest were initial and final BW, ADG, total BW gain, DMI, G:F, estrus activity, and carcass variables. Pen was the experimental unit for all variables. Mixed model procedures (SAS Institute Inc., Cary, NC) were used that included the random effects of block, the fixed effects of treatment, and treatment × block as the error term. Tests of treatment differences were based on least significant differences. Carcass measures that were categorically expressed included USDA QG and YG, liver abscesses, and dark-cutting carcasses. The response variables for categorically expressed carcass measures were evaluated as proportional carcass measures within pen and were analyzed using the GLIMMIX procedure (SAS Institute Inc.) with the same mixed model described above. Treatment differences for carcass quality and YG were based on the percentage of carcasses within a pen that graded Choice or better and had a YG of less than 4, respectively. Estrus activity was evaluated daily throughout the study and was divided into 21-d intervals for statistical evaluation. The total number of heifers within a pen that were observed showing standing heat in each 21-d interval was calculated and the totals were analyzed with a repeated-measures generalized mixed model that included the fixed effects of treatment, period of study (21-d interval) , and the treatment × period of study interaction and the random effects of block, the block × treatment interaction, and residual error. All generalized mixed model procedures assumed a logit link function and a binomial distribution, and estimates of least significant differences and SE were back-transformed to their observed scale.
RESULTS AND DISCUSSION
Results of heifer growth performance and feed consumption are presented in Table 2 for each treatment group. Body weights were simi-
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Comparing two melengestrol acetate doses fed to beef heifers (Bloss et al., 1966; Zimbelman and Smith, 1966) . The use of MGA in finishing diets may improve heifer performance by enhancing feed utilization through optimizing hormonal mechanisms that inhibit the preovulatory surge of luteinizing hormone, which prevents ovulation of dominate follicles (Imwalle et al., 2002) . Purchas et al. (1971) concluded that higher levels of estrogen in heifers treated with MGA plays a role in growth stimulation.
However, in an earlier study, Purchas et al. (1970) suggested MGA stimulates growth through suppressed adrenal cortical activity. Likewise, Moseley et al. (2003) showed a response to growth in MGA-treated steers (0.1 mg/d) with increased fat deposition and decreased LM area, indicating that part of the effects of MGA may involve a nonfollicular mechanism. Results of the current study indicate that any mechanisms by which MGA acts on growth, feed conversion, or carcass characteristics are not sensitive to dose variations between 0.4 and 0.5 mg/d. A major benefit of feeding MGA to feedlot heifers is through the suppression of estrus. Heifers expressing physical signs of estrus show increased physical activity (increased pedal activity and mounting) and physiological stress associated with recurring ovulation. Early titration studies of MGA indicated the minimum effective dose to inhibit ovulation in most cattle was 0.42 mg, with complete suppression of ovulation occurring with a daily dose of 0.50 mg . Young et al. (1969) also showed a minimum dose for optimal suppression of estrus of 0.4 mg/d in Angus heifers. Young et al. (1969) fed MGA at a dose of 0.0, 0.2, 0.4, and 0.6 mg/d per calf for 154 d and reported at least one incidence of observed estrus in 95.0, 70.6, 15.0, and 0.0% of the heifers, respectively, for each dose. In the current study, estrus activity was suppressed in both 0.4M and 0.5M groups when compared with negative controls of previous studies Young et al., 1969) , with fewer incidences of estrus associated with the 0.5M group. In the present study, a lower frequency of observed estrus at the 0.4-mg dose was observed compared with the results of Young et al. (1969) .
Heifers fed MGA for an extended period of time are expected to return to estrus approximately 3 to 7 d after MGA withdrawal Roussel and Beatty, 1969; Wettemann et al., 1973) . However, the effects of temporary intervals of reduced MGA intake on ovulation are unclear. Young et al. (1969) speculated that heifers broke through the estrus suppression effects of MGA and ovulated because of inconsistent consumption of MGA throughout the feeding interval of their field trial. It was suggested that maximum estrus suppression required heifers not to miss a single MGA feeding. In the presence of an antagonistic relationship between daily feed intake variability and estrus suppression in MGA-fed heifers, we might expect to see more estrus activity in groups fed at a lower MGA doses. In the current study, daily feed intake was not recorded for individual animals, and results reported herein do not validate this relationship between feed intake variation and estrus suppression. Overall carcass performance did not vary with MGA dose level (P > 0.10), with the exception of dark-cutting carcasses. Distributions of carcass USDA QG and YG as well as liver abscesses are presented in Tables 3  and 4 . Carcass quality was consistent between the 2 treatment groups, with the percentage of carcasses grading Choice or better within a pen ranging from 31.4 to 48.6% and 31.1 to 55.7% for 0.4M and 0.5M, respectively (data not shown). Distributions of YG were also similar, with the percentage of carcasses having a YG <4 ranging from 64.3 to 91.4% and 67.6 to 91.8% for 0.4M and 0.5M, respectively (data not shown). There was a trend (P = 0.10) for 0.4M heifers to exhibit a greater number of dark-cutting carcasses (3.0%) compared with 0.05M heifers (1.7%). Estimated mean values for calculated YG resulted in 0.09 YG units higher for 0.5M; however, this difference was not significant (P = 0.13). Bloss et al. (1966) and Lauderdale (1983) reported no difference in carcass characteristics in heifers fed different MGA dose levels, which is in agreement with data from the present study. Others, however, have reported increases in external fat deposition, reduced LM area (Mader and Lechtenberg, 2000) , or greater marbling scores (Macken et al., 2003; Kreikemeier and Mader, 2004) in MGA-fed heifers compared with heifers not fed MGA. The National Beef Quality Audit-2000 (McKenna et al., 2002 reported 2.3% dark-cutting beef carcasses in the US market. Differences in the frequency of darkcutting carcasses in this study only approached significance (3.0 and 1.7% for 0.4M and 0.5M, respectively; P = 0.09), but the differences do support an economic advantage for 0.5M heifers. Based on grid-pricing markets reported by the USDA (2008), the average discount placed on dark-cutting carcasses was $0.6486/kg of carcass weight (range of $0.3307 to $1.21). For this example ($0.6486) and results reported herein, the differences in carcass value for a pen of 100 heifers fed at the 0.4M versus 0.5M dose, both with a hot carcass average weight of 340 kg, would be $311.98 more for the 0.5M group [100 heifers × (1.7% × 340 kg × $0.6486) − (3.0% × 340 kg × $0.6486) = −$311.98].
The relationships between dark-cutting carcasses and environmental factors (management, season, sex) have been documented (Kreikemeier et al., 1998; Scanga et al., 1998) . However, the link between dark-cutting carcasses and heifer estrus is not clear. Scanga et al. (1998) evaluated commercial cattle over a 3-yr period (n = 11,663 pens of steers, n = 3,645 pens of heifers) and reported sex as having a significant effect on dark-cutting beef, with heifers averaging 0.3% more dark cutters per pen than steers (0.08% vs. 0.38% ± 0.001) for steers and heifers, respectively, throughout the study). Voisinet et al. (1997) indicated heifers were more excitable than older parous females. Kenny and Tarrant (1988) reported a negative relationship between muscle glycogen and estrus activity in heifers. Decreased muscle glycogen inhibits the reduction of muscle pH and results in dark-cutting beef (Ashmore et al., 1973) . Romans et al. (1988) showed heifers slaughtered during estrus tended to have darker cutting carcasses. The causal effects of these relationships have yet to be determined.
IMPLICATIONS
There have been numerous changes in the feedlot industry since MGA was first introduced in 1968. These include grain processing, breed type, mature BW, implant regimen, adaptation strategies, and dietary energy concentration. Despite all these changes, MGA appears to perform efficiently on a feedlot performance basis at the same FDA-approved lev- (Elanco, 1974) : 0 = healthy liver; 1 = 1 to 4 small abscesses; 2 = 1 to 4 medium abscesses; and 3 = 1 or more large abscesses.
els as when initially approved for use in 1968. Feeding MGA at the highest labeled dose may be economically beneficial in reducing the frequency of estrus activity and any associated dark-cutting carcasses within a group of heifers. However, variations in daily individual heifer feed intake need to be evaluated further to determine its influence on breaks in estrus suppression and dark-cutting carcasses in heifers fed at lower MGA doses.
